Literature DB >> 12126609

Approach to the Diagnosis and Management of Tuberculous Meningitis.

Scott W. Sinner1, Allan R. Tunkel.   

Abstract

Meningitis caused by Mycobacterium tuberculosis remains an important cause of morbidity and mortality worldwide, and presents specific challenges in terms of diagnosis and management. The nonspecific clinical presentation of tuberculous meningitis has led researchers to develop newer biochemical and molecular methods of making the diagnosis. Several of these methods have excellent sensitivity and specificity, although are not yet available for clinical use. Successful therapy for tuberculous meningitis requires a combination of antimicrobial agents, with vigilance towards the possibility of disease caused by resistant organisms. Adjunctive corticosteroids also have a role in treating this potentially devastating infection. With proper therapy, morbidity and mortality can be minimized in patients with tuberculous meningitis.

Entities:  

Year:  2002        PMID: 12126609     DOI: 10.1007/s11908-002-0025-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  42 in total

1.  Thalidomide therapy in childhood tuberculous menigitis.

Authors:  J F Schoeman
Journal:  J Child Neurol       Date:  2000-12       Impact factor: 1.987

2.  A comparative evaluation of dot immunobinding assay (Dot-Iba) and polymerase chain reaction (PCR) for the laboratory diagnosis of tuberculous meningitis.

Authors:  M G Sumi; A Mathai; S Reuben; C Sarada; V V Radhakrishnan; R Indulakshmi; M Sathish; R Ajaykumar; Y K Manju
Journal:  Diagn Microbiol Infect Dis       Date:  2002-01       Impact factor: 2.803

3.  Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis.

Authors:  M Caws; S M Wilson; C Clough; F Drobniewski
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  A diagnostic rule for tuberculous meningitis.

Authors:  R Kumar; S N Singh; N Kohli
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

5.  Does BCG vaccine prevent tuberculous meningitis?

Authors:  N Thilothammal; P V Krishnamurthy; D K Runyan; K Banu
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

6.  Multidrug-resistant tuberculosis meningitis: clinical problems and concentrations of second-line antituberculous medications.

Authors:  J P DeVincenzo; S E Berning; C A Peloquin; R N Husson
Journal:  Ann Pharmacother       Date:  1999-11       Impact factor: 3.154

7.  Anti-purified protein derivative cell-enzyme-linked immunosorbent assay, a sensitive method for early diagnosis of tuberculous meningitis.

Authors:  S M Baig
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

8.  The use of dexamethasone in preventing ocular complications in tuberculous meningitis.

Authors:  N I Girgis; Z Farid; L S Hanna; M W Yassin; C K Wallace
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

9.  Rapid diagnosis of tuberculous meningitis by a dot immunobinding assay To detect mycobacterial antigen in cerebrospinal fluid specimens.

Authors:  M G Sumi; A Mathai; C Sarada; V V Radhakrishnan
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

10.  Diagnosis and treatment of complicated tubercular meningitis.

Authors:  J J Kelly; E A Horowitz; C J Destache; A H Fruin; V A Long
Journal:  Pharmacotherapy       Date:  1999-10       Impact factor: 4.705

View more
  1 in total

1.  Dexamethasone for Treatment of Tuberculous Meningitis in Adolescents and Adults.

Authors:  Allan R Tunkel
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.